A retrospective study is to investigate the relationship between BMI and efficacy of ICI treatment in patients with advanced NSCLC
Latest Information Update: 19 Feb 2021
At a glance
- Drugs Atezolizumab (Primary) ; Nivolumab (Primary) ; Pembrolizumab (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 19 Feb 2021 New trial record